These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Effects of chirality at Tyr13 on the structure-activity relationships of omega-conotoxins from Conus magus. Nielsen KJ; Adams DA; Alewood PF; Lewis RJ; Thomas L; Schroeder T; Craik DJ Biochemistry; 1999 May; 38(21):6741-51. PubMed ID: 10346894 [TBL] [Abstract][Full Text] [Related]
12. Solution structure of omega-conotoxin MVIIC, a high affinity ligand of P-type calcium channels, using 1H NMR spectroscopy and complete relaxation matrix analysis. Farr-Jones S; Miljanich GP; Nadasdi L; Ramachandran J; Basus VJ J Mol Biol; 1995 Apr; 248(1):106-24. PubMed ID: 7731037 [TBL] [Abstract][Full Text] [Related]
13. Three-dimensional solution structure of the calcium channel antagonist omega-agatoxin IVA: consensus molecular folding of calcium channel blockers. Kim JI; Konishi S; Iwai H; Kohno T; Gouda H; Shimada I; Sato K; Arata Y J Mol Biol; 1995 Jul; 250(5):659-71. PubMed ID: 7623383 [TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of omega-conotoxins MVIIA, MVIIC and 14 loop splice hybrids at N and P/Q-type calcium channels. Nielsen KJ; Adams D; Thomas L; Bond T; Alewood PF; Craik DJ; Lewis RJ J Mol Biol; 1999 Jun; 289(5):1405-21. PubMed ID: 10373375 [TBL] [Abstract][Full Text] [Related]
15. A consensus structure for omega-conotoxins with different selectivities for voltage-sensitive calcium channel subtypes: comparison of MVIIA, SVIB and SNX-202. Nielsen KJ; Thomas L; Lewis RJ; Alewood PF; Craik DJ J Mol Biol; 1996 Oct; 263(2):297-310. PubMed ID: 8913308 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of toxicity of N-type calcium channel inhibitor MVIIA. Wang F; Yan Z; Liu Z; Wang S; Wu Q; Yu S; Ding J; Dai Q Neuropharmacology; 2016 Feb; 101():137-45. PubMed ID: 26344359 [TBL] [Abstract][Full Text] [Related]
17. Effects of Lys2 to Ala2 substitutions on the structure and potency of ω-conotoxins MVIIA and CVID. Schroeder CI; Nielsen KJ; Adams DA; Loughnan M; Thomas L; Alewood PF; Lewis RJ; Craik DJ Biopolymers; 2012; 98(4):345-56. PubMed ID: 23193599 [TBL] [Abstract][Full Text] [Related]
18. Solution structure determination by two-dimensional 1H NMR of omega-conotoxin MVIID, a calcium channel blocker peptide. Civera C; Vázquez A; Sevilla JM; Bruix M; Gago F; García AG; Sevilla P Biochem Biophys Res Commun; 1999 Jan; 254(1):32-5. PubMed ID: 9920728 [TBL] [Abstract][Full Text] [Related]
19. Design and biological evaluation of non-peptide analogues of omega-conotoxin MVIIA. Menzler S; Bikker JA; Suman-Chauhan N; Horwell DC Bioorg Med Chem Lett; 2000 Feb; 10(4):345-7. PubMed ID: 10714496 [TBL] [Abstract][Full Text] [Related]
20. A new omega-conotoxin that targets N-type voltage-sensitive calcium channels with unusual specificity. Favreau P; Gilles N; Lamthanh H; Bournaud R; Shimahara T; Bouet F; Laboute P; Letourneux Y; Ménez A; Molgó J; Le Gall F Biochemistry; 2001 Dec; 40(48):14567-75. PubMed ID: 11724570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]